{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Merck", "item": "https://www.patentleaderboard.com/company/merck"}, {"@type": "ListItem", "position": 3, "name": "Rolf Thieringer", "item": "https://www.patentleaderboard.com/inventor/fl:ro_ln:thieringer-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RT

Rolf Thieringer — 2 Patents

Merck: 2 patents #3,930 of 9,382Top 45%
Highland Park, NJ: #188 of 409 inventorsTop 50%
New Jersey: #30,063 of 69,400 inventorsTop 45%
Overall (All Time): #1,709,992 of 4,157,543Top 45%
2 Patents All Time
Rolf Thieringer has been granted 2 US patents while listed as an inventor at Merck. The first was granted in 2008 and the most recent in April 2010. Rolf Thieringer ranks #1,709,992 of 4,157,543 US inventors in our database (top 41.1%). Patent records list Rolf Thieringer in Highland Park, NJ, US.

Issued Patents All Time

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7691887 Triazole derivatives which are SMO antagonists James M. Balkovec, Sherman T. Waddell 2010-04-06 $50,617,000
7329683 11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia James M. Balkovec, Steven S. Mundt, Anne Hermanowski-Vosatka, Donald W. Graham, Gool F. Patel +4 more 2008-02-12 $61,671,000